Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
22.75
-0.10 (-0.44%)
At close: Jan 8, 2026, 4:00 PM EST
23.24
+0.49 (2.15%)
Pre-market: Jan 9, 2026, 7:04 AM EST
Fresenius Medical Care AG Market Cap
Fresenius Medical Care AG has a market cap or net worth of $12.7 billion as of January 9, 2026. Its market cap has decreased by -5.10% in one year.
Market Cap
12.70B
Enterprise Value
24.57B
1-Year Change
-5.10%
Ranking
Category
Stock Price
$22.75
Market Cap Chart
Since December 1, 1998, Fresenius Medical Care AG's market cap has increased from $5.99B to $12.70B, an increase of 112.20%. That is a compound annual growth rate of 2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 13.19B | -4.49% |
| Dec 31, 2025 | 13.81B | 3.93% |
| Dec 31, 2024 | 13.29B | 8.69% |
| Dec 29, 2023 | 12.22B | 27.48% |
| Dec 30, 2022 | 9.59B | -49.57% |
| Dec 31, 2021 | 19.01B | -23.32% |
| Dec 31, 2020 | 24.80B | 9.70% |
| Dec 31, 2019 | 22.60B | 13.87% |
| Dec 31, 2018 | 19.85B | -38.32% |
| Dec 29, 2017 | 32.18B | 24.87% |
| Dec 30, 2016 | 25.77B | 2.18% |
| Dec 31, 2015 | 25.23B | 12.65% |
| Dec 31, 2014 | 22.39B | 3.94% |
| Dec 31, 2013 | 21.54B | 4.62% |
| Dec 31, 2012 | 20.59B | 1.55% |
| Dec 30, 2011 | 20.28B | 18.85% |
| Dec 31, 2010 | 17.06B | 9.93% |
| Dec 31, 2009 | 15.52B | 12.36% |
| Dec 31, 2008 | 13.81B | -10.15% |
| Dec 31, 2007 | 15.37B | 64.77% |
| Dec 29, 2006 | 9.33B | 131.35% |
| Dec 31, 2002 | 4.03B | -31.05% |
| Dec 31, 2001 | 5.85B | -26.55% |
| Dec 29, 2000 | 7.96B | -4.19% |
| Dec 31, 1999 | 8.31B | 20.77% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |